Lazard Asset Management’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Buy |
168,979
+30,621
| +22% | +$637K | 0.01% | 668 |
|
|
2025
Q4 | $2.96M | Buy |
138,358
+35,349
| +34% | +$724K | 0.01% | 722 |
|
|
2025
Q3 | $1.73M | Buy |
103,009
+13,797
| +15% | +$207K | ﹤0.01% | 911 |
|
|
2025
Q2 | $1.28M | Buy |
+89,212
| New | +$1.22M | ﹤0.01% | 1192 |
|
|
2025
Q1 | – | Sell |
-66,204
| Closed | -$868K | – | 2459 |
|
|
2024
Q4 | $868K | Buy |
+66,204
| New | +$914K | ﹤0.01% | 1204 |
|
|
2024
Q1 | – | Sell |
-20,940
| Closed | -$194K | – | 2242 |
|
|
2023
Q4 | $194K | Sell |
20,940
-8,212,821
| -100% | -$84.9M | ﹤0.01% | 1389 |
|
|
2023
Q3 | $105M | Buy |
8,233,761
+45,698
| +0.6% | +$627K | 0.14% | 135 |
|
|
2023
Q2 | $116M | Buy |
8,188,063
+51,947
| +0.6% | +$729K | 0.14% | 134 |
|
|
2023
Q1 | $121M | Buy |
8,136,116
+1,148,296
| +16% | +$17.4M | 0.16% | 124 |
|
|
2022
Q4 | $104M | Buy |
6,987,820
+967,897
| +16% | +$15.8M | 0.14% | 128 |
|
|
2022
Q3 | $99.4M | Buy |
6,019,923
+1,678,258
| +39% | +$33.8M | 0.15% | 134 |
|
|
2022
Q2 | $91.2M | Buy |
4,341,665
+1,077,966
| +33% | +$22M | 0.12% | 153 |
|
|
2022
Q1 | $76.6M | Buy |
3,263,699
+637,798
| +24% | +$15.6M | 0.09% | 199 |
|
|
2021
Q4 | $71.5M | Buy |
2,625,901
+256,617
| +11% | +$6.87M | 0.08% | 229 |
|
|
2021
Q3 | $67.4M | Buy |
2,369,284
+92,063
| +4% | +$2.81M | 0.08% | 228 |
|
|
2021
Q2 | $68.7M | Sell |
2,277,221
-409,850
| -15% | -$12.1M | 0.08% | 221 |
|
|
2021
Q1 | $68.4M | Sell |
2,687,071
-801,997
| -23% | -$20.5M | 0.08% | 203 |
|
|
2020
Q4 | $85.6M | Buy |
3,489,068
+1,185,912
| +51% | +$22.3M | 0.11% | 167 |
|
|
2020
Q3 | $37.5M | Buy |
2,303,156
+51,052
| +2% | +$950K | 0.05% | 274 |
|
|
2020
Q2 | $38.5M | Sell |
2,252,104
-1,160,405
| -34% | -$17.2M | 0.06% | 224 |
|
|
2020
Q1 | $39.7M | Sell |
3,412,509
-524,583
| -13% | -$10.8M | 0.07% | 192 |
|
|
2019
Q4 | $109M | Buy |
3,937,092
+687,215
| +21% | +$17.2M | 0.16% | 124 |
|
|
2019
Q3 | $73.5M | Buy |
3,249,877
+992,282
| +44% | +$22.6M | 0.12% | 145 |
|
|
2019
Q2 | $57M | Buy |
2,257,595
+866,925
| +62% | +$23.3M | 0.09% | 162 |
|
|
2019
Q1 | $37.8M | Buy |
1,390,670
+835,444
| +150% | +$28M | 0.06% | 213 |
|
|
2018
Q4 | $18.3M | Buy |
+555,226
| New | +$22.3M | 0.03% | 310 |
|
|
2018
Q2 | – | Sell |
-106
| Closed | -$5K | – | 1092 |
|
|
2018
Q1 | $5K | Hold |
106
| – | – | ﹤0.01% | 995 |
|
|
2017
Q4 | $5K | Hold |
106
| – | – | ﹤0.01% | 1012 |
|
|
2017
Q3 | $4K | Sell |
106
-295,343
| -100% | -$14M | ﹤0.01% | 941 |
|
|
2017
Q2 | $17.8M | Buy |
295,449
+68,365
| +30% | +$4.05M | 0.03% | 321 |
|
|
2017
Q1 | $15.8M | Sell |
227,084
-48,405
| -18% | -$3.36M | 0.03% | 357 |
|
|
2016
Q4 | $18.4M | Buy |
275,489
+88,500
| +47% | +$5.76M | 0.04% | 296 |
|
|
2016
Q3 | $12.4M | Buy |
186,989
+11,393
| +6% | +$779K | 0.02% | 367 |
|
|
2016
Q2 | $12.7M | Buy |
175,596
+8,367
| +5% | +$575K | 0.03% | 335 |
|
|
2016
Q1 | $10.8M | Buy |
167,229
+1,000
| +0.6% | +$66.3K | 0.02% | 360 |
|
|
2015
Q4 | $11.9M | Buy |
166,229
+44,911
| +37% | +$3.32M | 0.03% | 346 |
|
|
2015
Q3 | $9.31M | Sell |
121,318
-28,500
| -19% | -$2.3M | 0.02% | 387 |
|
|
2015
Q2 | $11.1M | Buy |
149,818
+6,000
| +4% | +$432K | 0.02% | 363 |
|
|
2015
Q1 | $10.4M | Sell |
143,818
-68,830
| -32% | -$4.79M | 0.02% | 378 |
|
|
2014
Q4 | $14.1M | Buy |
212,648
+65,693
| +45% | +$4.01M | 0.03% | 324 |
|
|
2014
Q3 | $8.05M | Buy |
146,955
+6,377
| +5% | +$362K | 0.02% | 431 |
|
|
2014
Q2 | $8.17M | Sell |
140,578
-3,500
| -2% | -$206K | 0.02% | 442 |
|
|
2014
Q1 | $8.93M | Buy |
144,078
+8,248
| +6% | +$480K | 0.02% | 392 |
|
|
2013
Q4 | $7.25M | Buy |
135,830
+18,152
| +15% | +$974K | 0.02% | 436 |
|
|
2013
Q3 | $5.91M | Sell |
117,678
-22,000
| -16% | -$1.07M | 0.01% | 468 |
|
|
2013
Q2 | $6.39M | Buy |
+139,678
| New | +$6.25M | 0.02% | 461 |
|
Other funds holding MD
VPM
VCM
WA
Lazard Asset Management's MD Position: Q1 2026 in Review
Lazard Asset Management increased its Pediatrix Medical (MD) stake by 22% in Q1 2026, buying an estimated $637K and bringing the position to 168,979 shares worth $3.61M. The position accounts for 0.01% of the portfolio, ranked #668.
Lazard Asset Management first reported a position in MD in Q2 2013 and has held it in 46 quarters since. The position peaked at $121M in Q1 2023. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Lazard Asset Management held 168,979 shares of Pediatrix Medical worth $3.61M as of Q1 2026.
- Lazard Asset Management bought 30,621 Pediatrix Medical shares in Q1 2026, an estimated $637K.
- Pediatrix Medical made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #668 holding.
- Lazard Asset Management first reported a position in Pediatrix Medical in Q2 2013 and has held it in 46 quarters since.
- Lazard Asset Management's Pediatrix Medical position peaked at $121M in Q1 2023.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.